You are here
CymaBay Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
NEWARK, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that management will participate in a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY. The presentation will begin at 10:30 a.m. Eastern Time on Wednesday, February 27, 2019.
Wednesday, February 20, 2019 - 08:00